Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 4,151–4,175 of 7,816 matching trials · page 167 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Comparison of Dual Assignment, Cadence, and Gait Speed in Alzheimer's Dementia and Healthy Geriatric Individuals NCT05767580 evaluation |
NA other |
UNKNOWN | 50 | Kırıkkale University OTHER |
2023-03-14 |
|
Network-based rTMS in Alzheimer's Disease NCT04263194 rTMS; Sham rTMS Runs in: Italy · 1 site |
NA other |
UNKNOWN | 60 | IRCCS Centro San Giovanni di Dio Fatebenefratelli OTHER |
2023-03-13 |
|
Equality in Caregiving: Facilitating Caregiver Mastery Among LGBT Caregivers of PLWD NCT04394260 Savvy Caregiver Program via Remote Learning; Focus group Runs in: United States · 1 site |
NA other |
COMPLETED | 10 | Emory University OTHER |
2023-03-10 |
|
REACH Hope Intervention for Dementia and TBI Caregivers NCT04969796 REACH Hope Runs in: United States · 1 site |
NA other |
UNKNOWN | 110 | Memphis VA Medical Center OTHER_GOV |
2023-03-10 |
|
Motor-cognitive Interventions Are Effective in Improving Cognitive Function in Older Adults With Mild Cognitive impairment--a Chinese Sample NCT05764421 motor-cognitive intervention Runs in: China · 1 site |
NA other |
COMPLETED | 103 | Jinxuan Cheng OTHER |
2023-03-10 |
|
Live@Home.Path: Innovating the Clinical Pathway for Home Dwelling Persons With Dementia and Their Families NCT04043364 LIVE Runs in: Norway · 1 site |
NA other |
UNKNOWN | 280 | University of Bergen OTHER |
2023-03-09 |
|
Comparison of Kinesiophobia, Balance, Falling and Walking Speeds of Elderly's With Physical Frailty With Alzheimer's NCT05761665 Evaluation |
NA other |
UNKNOWN | 54 | Kırıkkale University OTHER |
2023-03-09 |
|
Plasma Hydrogen Sulfide as a Biomarker for Alzheimer's Disease and Related Dementias NCT05060848 Runs in: United States · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 100 | Louisiana State University Health Sciences Center Shreveport OTHER |
2023-03-08 |
|
Prognosis of Cerebral Small Vessel Disease NCT05734378 Runs in: Switzerland · 1 site |
NA other |
RECRUITING | 900 | Insel Gruppe AG, University Hospital Bern OTHER |
2023-03-08 |
|
Comparison Between Parkinson's Disease and Parkinson's Dementia Complex (Genetically,Clinical and Electrophysiological) NCT05759403 Cortical excitability using transcranial magnetic stimulation Runs in: Egypt · 1 site |
NA other |
UNKNOWN | 40 | Assiut University OTHER |
2023-03-08 |
|
Cognitive Impairment and Affective Mood Disorders in Patients With IBD NCT05760729 Cognitive testing Runs in: Romania · 3 sites |
NA other |
UNKNOWN | 75 | Iuliu Hatieganu University of Medicine and Pharmacy OTHER |
2023-03-08 |
|
Cognitive and Aerobic Resilience for the Brain NCT02390453 Combined Cognitive and Physical; Cognitive; Physical; Active Control Runs in: United States · 1 site |
NA other |
COMPLETED | 201 | Indiana University OTHER |
2023-03-07 |
|
Testing the Implementation of EIT-4-BPSD NCT03014570 EIT-4-BPSD; Education-only Control Runs in: United States · 1 site |
NA other |
COMPLETED | 553 | University of Maryland, Baltimore OTHER |
2023-03-07 |
|
A Telehealth Advance Care Planning Intervention in Those With Mild Cognitive Impairment or Unrecognized Dementia NCT04912245 Telehealth visit Runs in: United States · 7 sites |
NA other |
COMPLETED | 152 | Wake Forest University Health Sciences OTHER |
2023-03-07 |
|
Senolytic Therapy to Modulate Progression of Alzheimer's Disease NCT04063124 Dasatinib + Quercetin Runs in: United States · 1 site |
PHASE1|PHASE2 other |
COMPLETED | 5 | The University of Texas Health Science Center at San Antonio OTHER |
2023-03-06 |
|
Therapeutic Effectiveness of PARO Companion Robot for Elderly With Mild Cognitive Impairment/Dementia in Elderly Residential Setting: A Quasi-experimental Study NCT05404802 Experimental group intervention; Control group intervention Runs in: Hong Kong · 2 sites |
NA other |
COMPLETED | 37 | The University of Hong Kong OTHER |
2023-03-06 |
|
Implementation and Evaluation of Improved Access to Medical Imaging for Geriatric Patients of The Royal Ottawa Hospital NCT05428475 [18F]FDG-PET Scan |
PHASE3 other |
UNKNOWN | 15 | Tim Lau OTHER |
2023-03-06 |
|
Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS) NCT01650792 Aspirin Runs in: Brazil · 1 site |
PHASE4 other |
UNKNOWN | 500 | Federal University of Bahia OTHER |
2023-03-03 |
|
Transcranial Magnetic Stimulation (TMS) Treatment for Alzheimer Patients NCT01334450 TMS , H2-coil Runs in: Israel · 1 site |
PHASE2 other |
COMPLETED | 10 | Hadassah Medical Organization OTHER |
2023-03-02 |
|
Remember Stuff: A Dyadic-focused Technology to Support Persons With Alzheimer's Disease in the Community NCT04626804 Remember Stuff: A Dyadic-focused Technology to Support Persons with... Runs in: United States · 1 site |
NA other |
COMPLETED | 30 | Indiana University OTHER |
2023-03-01 |
|
Effects of Hericium Erinaceus on Microbiota and Cognition NCT04939961 Hericium erinaceus; Placebo Runs in: Slovenia · 1 site |
NA other |
COMPLETED | 40 | University of Primorska OTHER |
2023-03-01 |
|
Posiphen® Dose-Finding, Biomarker Study in Early Alzheimer's and Parkinson's Patients NCT04524351 Posiphen; Placebo Runs in: United States · 13 sites |
PHASE1|PHASE2 other |
COMPLETED | 75 | Annovis Bio Inc. INDUSTRY |
2023-02-28 |
|
Long-term Effect of θ Burst Magnetic Stimulation on Clinical Symptoms of Alzheimer Disease NCT04754152 θ burst transcranial magnetic stimulation; Pharmacotherapy Runs in: China · 1 site |
NA other |
COMPLETED | 45 | Anhui Medical University OTHER |
2023-02-28 |
|
Effectiveness of Non-pharmacological Interventions for Dementia Among Elderly in Hai Duong Province, Vietnam NCT05351723 Exercise + cognitive training + education Runs in: Vietnam · 1 site |
NA other |
COMPLETED | 88 | Hanoi Medical University OTHER |
2023-02-28 |
|
A Natural History Study of Preclinical Genetic Creutzfeldt-Jakob Disease (CJD) NCT05746715 Runs in: Israel · 1 site |
NA other |
RECRUITING | 126 | Tel-Aviv Sourasky Medical Center OTHER_GOV |
2023-02-28 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial